Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


14.10.2019

1 Ann Oncol
3 Anticancer Res
4 Breast Cancer Res Treat
1 Breast J
1 Cancer
1 Clin Breast Cancer
4 Clin Cancer Res
1 Clin Exp Metastasis
1 Eur J Surg Oncol
5 Int J Cancer
3 Int J Radiat Oncol Biol Phys
4 J Natl Cancer Inst
1 Lancet Oncol
1 Nature
1 NPJ Breast Cancer
1 Oncogene
1 PLoS Comput Biol
2 PLoS One
2 Proc Natl Acad Sci U S A
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. FERREIRA AR, Di Meglio A, Pistilli B, Gbenou AS, et al
    Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
    Ann Oncol. 2019 Oct 8. pii: 5583691. doi: 10.1093.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. CANALE ML, Camerini A, Huqi A, Lilli A, et al
    Cardiovascular Risk Factors and Timing of Anthracyclines and Trastuzumab Cardiac Toxicity.
    Anticancer Res. 2019;39:5741-5745.
    PubMed     Text format     Abstract available

  3. SUSINI T, Renda I, Giani M, Vallario A, et al
    Changing Trends in Mastectomy and Breast Reconstruction. Analysis of a Single-institution Experience Between 2004-2016.
    Anticancer Res. 2019;39:5709-5714.
    PubMed     Text format     Abstract available

  4. WOO HY, DO SI, Kim SH, Song SY, et al
    Promoter Methylation Down-regulates B-cell Translocation Gene 1 Expression in Breast Carcinoma.
    Anticancer Res. 2019;39:5361-5367.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  5. GONZALEZ-RODRIGUEZ E, Aubry-Rozier B, Stoll D, Zaman K, et al
    Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors.
    Breast Cancer Res Treat. 2019 Oct 9. pii: 10.1007/s10549-019-05458.
    PubMed     Text format     Abstract available

  6. HWANG KT, Kim J, Jung J, Kim BH, et al
    Long-term prognostic effect of hormone receptor subtype on breast cancer.
    Breast Cancer Res Treat. 2019 Oct 8. pii: 10.1007/s10549-019-05456.
    PubMed     Text format     Abstract available

  7. ALJOHANI AI, Toss MS, Kurozumi S, Joseph C, et al
    The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.
    Breast Cancer Res Treat. 2019 Oct 10. pii: 10.1007/s10549-019-05459.
    PubMed     Text format     Abstract available

  8. SHI Z, Rundle A, Genkinger JM, Cheung YK, et al
    Distinct trajectories of fruits and vegetables, dietary fat, and alcohol intake following a breast cancer diagnosis: the Pathways Study.
    Breast Cancer Res Treat. 2019 Oct 10. pii: 10.1007/s10549-019-05457.
    PubMed     Text format     Abstract available


    Breast J

  9. YANG K, Chun M
    Radiation recall dermatitis in response to adjuvant capecitabine immediately following postoperative radiotherapy in a patient with breast cancer.
    Breast J. 2019 Oct 3. doi: 10.1111/tbj.13627.
    PubMed     Text format     Abstract available


    Cancer

  10. YADAV S, Karam D, Bin Riaz I, Xie H, et al
    Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century.
    Cancer. 2019 Oct 7. doi: 10.1002/cncr.32472.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  11. JIANG L, Li X, Kong X, Ma T, et al
    Galactogram Grading System for Identifying Breast Cancer With Nipple Discharge.
    Clin Breast Cancer. 2019 Aug 22. pii: S1526-8209(19)30658.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  12. PEGRAM MD, Miles D, Tsui CK, Zong Y, et al
    HER2-overexpressing/amplified breast cancer as a testing ground for antibody-drug conjugate drug development in solid tumors.
    Clin Cancer Res. 2019 Oct 3. pii: 1078-0432.CCR-18-1976.
    PubMed     Text format     Abstract available

  13. YANG Y, Yang H, Tang B, Wu AML, et al
    The outcome of TGFbeta antagonism in metastatic breast cancer models in vivo reflects a complex balance between tumor-suppressive and pro-progression activities of TGFbeta.
    Clin Cancer Res. 2019 Oct 3. pii: 1078-0432.CCR-19-2370.
    PubMed     Text format     Abstract available

  14. PEARSON A, Proszek PZ, Pascual J, Fribbens C, et al
    Inactivating NF1 mutations are enriched in advanced breast cancer and contribute to endocrine therapy resistance.
    Clin Cancer Res. 2019 Oct 7. pii: 1078-0432.CCR-18-4044.
    PubMed     Text format     Abstract available

  15. QUINTELA-FANDINO M, Morales S, Cortes-Salgado A, Manso L, et al
    Randomized phase 0/I trial of the mitochondrial inhibitor ME-344 or placebo added to bevacizumab in early HER2-negative breast cancer.
    Clin Cancer Res. 2019 Oct 9. pii: 1078-0432.CCR-19-2023.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  16. FUJITA R, Hamano H, Kameda Y, Arai R, et al
    Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization.
    Clin Exp Metastasis. 2019 Oct 8. pii: 10.1007/s10585-019-09999.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  17. PERHAVEC A, Miklavcic M, Peric B, Pilko G, et al
    Is preoperative ultrasound of the axilla necessary in screen-detected breast cancer?
    Eur J Surg Oncol. 2019 Sep 19. pii: S0748-7983(19)30813.
    PubMed     Text format     Abstract available


    Int J Cancer

  18. KINOSHITA R, Sato H, Yamauchi A, Takahashi Y, et al
    exSSSRs (extracellular S100 soil sensor receptors)-Fc fusion proteins work as prominent decoys to S100A8/A9-induced lung tropic cancer metastasis.
    Int J Cancer. 2019;144:3138-3145.
    PubMed     Text format     Abstract available

  19. SINGH D, Malila N, Pitkaniemi J, Anttila A, et al
    Cancer incidence and mortality patterns in women with breast symptoms in the mammography screening programme: A matched cohort analysis.
    Int J Cancer. 2019;144:2928-2935.
    PubMed     Text format     Abstract available

  20. VAN HEMELRIJCK WMJ, De Schutter H, de Valk HAG, Silversmit G, et al
    Breast cancer by migrant background in Belgium: lower risk, but worse survival in women of non-European origin.
    Int J Cancer. 2019 Oct 9. doi: 10.1002/ijc.32726.
    PubMed     Text format     Abstract available

  21. LUO J, Chen X, Manson JE, Shadyab AH, et al
    Birth weight, weight over the adult life course, and risk of breast cancer.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32710.
    PubMed     Text format     Abstract available

  22. AYENI OA, Norris SA, Joffe M, Cubasch H, et al
    The multimorbidity profile of South African women newly diagnosed with breast cancer.
    Int J Cancer. 2019 Oct 10. doi: 10.1002/ijc.32727.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  23. STECKLEIN SR, Shaitelman SF
    In Reply to Mailhot et al.
    Int J Radiat Oncol Biol Phys. 2019;103:1281.
    PubMed     Text format    

  24. MAILHOT VEGA RB, Lockney NA, MacDonald SM, Mendenhall NP, et al
    In Regard to Stecklein et al.
    Int J Radiat Oncol Biol Phys. 2019;103:1280-1281.
    PubMed     Text format    

  25. TORRES MA
    Genomic Assays to Assess Local Recurrence Risk and Predict Radiation Therapy Benefit in Patients With Ductal Carcinoma In Situ.
    Int J Radiat Oncol Biol Phys. 2019;103:1021-1025.
    PubMed     Text format    


    J Natl Cancer Inst

  26. MACINNIS RJ, Liao Y, Knight JA, Milne RL, et al
    Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results.
    J Natl Cancer Inst. 2019 Oct 4. pii: 5581413. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. DEMB J, Abraham L, Miglioretti DL, Sprague BL, et al
    Screening mammography outcomes: risk of breast cancer and mortality by comorbidity score and age.
    J Natl Cancer Inst. 2019 Sep 6. pii: 5556084. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. SPENCER JC, Rotter JS, Eberth JM, Zahnd WE, et al
    Employment changes following breast cancer diagnosis: the effects of race and place.
    J Natl Cancer Inst. 2019 Oct 10. pii: 5585013. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. DEKKERS JF, Whittle JR, Vaillant F, Chen HR, et al
    Modeling breast cancer using CRISPR/Cas9-mediated engineering of human breast organoids.
    J Natl Cancer Inst. 2019 Oct 7. pii: 5582651. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet Oncol

  30. STIRRUPS R
    Abemaciclib plus fulvestrant for breast cancer.
    Lancet Oncol. 2019 Oct 3. pii: S1470-2045(19)30629.
    PubMed     Text format    


    Nature

  31. KISER B
    Psychedelic psychiatry, breast cancer, and a paean to the emperor penguin: Books in brief.
    Nature. 2019;574:175.
    PubMed     Text format    


    NPJ Breast Cancer

  32. COLLIN LJ, Yan M, Jiang R, Ward KC, et al
    Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia.
    NPJ Breast Cancer. 2019;5:32.
    PubMed     Text format     Abstract available


    Oncogene

  33. WILLIAMS CB, Phelps-Polirer K, Dingle IP, Williams CJ, et al
    HUNK phosphorylates EGFR to regulate breast cancer metastasis.
    Oncogene. 2019 Oct 9. pii: 10.1038/s41388-019-1046.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  34. CHAPMAN MP, Risom T, Aswani AJ, Langer EM, et al
    Correction: Modeling differentiation-state transitions linked to therapeutic escape in triple-negative breast cancer.
    PLoS Comput Biol. 2019;15:e1007441.
    PubMed     Text format     Abstract available


    PLoS One

  35. LEE KJ, Piett CG, Andrews JF, Mann E, et al
    Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer.
    PLoS One. 2019;14:e0223725.
    PubMed     Text format     Abstract available

  36. ZHAI Q, Fan J, Lin Q, Liu X, et al
    Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer.
    PLoS One. 2019;14:e0223325.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  37. HE C, Danes JM, Hart PC, Zhu Y, et al
    SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer.
    Proc Natl Acad Sci U S A. 2019 Oct 7. pii: 1902308116.
    PubMed     Text format     Abstract available

  38. HAGERLING C, Gonzalez H, Salari K, Wang CY, et al
    Immune effector monocyte-neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer.
    Proc Natl Acad Sci U S A. 2019 Oct 7. pii: 1907660116.
    PubMed     Text format     Abstract available


    Radiology

  39. AMORNSIRIPANITCH N, Bickelhaupt S, Shin HJ, Dang M, et al
    Diffusion-weighted MRI for Unenhanced Breast Cancer Screening.
    Radiology. 2019 Oct 8:182789. doi: 10.1148/radiol.2019182789.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: